Physician profile
Tina Boucher
NPI 1518945401
$4,029.04
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $728 · 2020: $117 · 2021: $146 · 2022: $2,508 · 2023: $293 · 2024: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $529.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,396.40 | 2019-2022 | |
| Treace Medical Concepts, INC. | $1,057.63 | 2022 | |
| Organogenesis INC. | $273.97 | 2019-2024 | Puraply |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $223.89 | 2019-2024 | Jublia |
| Pfizer INC. | $172.63 | 2019 | |
| Sebela Pharmaceuticals INC. | $149.46 | 2019-2023 | Naftin |
| Grt US Holding, INC. | $133.22 | 2021-2022 | |
| Abbott Laboratories | $116.93 | 2019 | |
| Vaporox, INC. | $89.58 | 2023 | Vht-200 Wound Treatment System |
| Reapplix INC. | $75.35 | 2024 | 3c Patch Kit - Box |
| Journey Medical Corporation | $73.93 | 2022-2024 | |
| Reprise Biomedical, INC. | $68.51 | 2024 | Miro3d |
| Bioventus LLC | $45.68 | 2019 | |
| Stryker Corporation | $39.43 | 2019 | |
| Bone Support INC. | $23.78 | 2024 | Cerament G, Ceramentbone Void Filler |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $22.26 | 2021 | |
| Hydrofera LLC | $19.27 | 2023 | Cutimed Sorbact |
| Paratek Pharmaceuticals, INC. | $17.53 | 2023 | Nuzyra |
| Melinta Therapeutics, LLC | $15.25 | 2019 | |
| Mimedx Group, INC. | $14.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tina Boucher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.